Page 23 - Pharma Companies

Price drives growth of Rs 1.4 trillion pharma market, hits a five-year high

The rapid growth of the trade generics market which accounts for a third of pharma volumes is another trend which is impacting volume as well as overall growth of the branded segment

Day 1 of lockdown 3.0: India limps back, but industry still in limbo

With public transport still not allowed in 130 red-zone districts, which comprise some of the economically important urban centres, people took out their private vehicles.

Covid-19 lockdown: Domestic pharma growth takes hit as stock piles up

Inventory days have gone up from 31 days as on March 22 to 41 days as on April 22

Coronavirus impact: Top pharma companies fare better during lockdown

New launches stagnate as fresh prescriptions dry up

Gilead's antiviral drug remedesivir being made in India on trial basis

Local drug makers start developing patented drug as govt too wishes to try it on Indians

Order inflow to improve for manufacturers of specialty chemicals

Galaxy Surfactants, SRF, Aarti Industries among companies to benefit given supply of essential ingredients, alternative supply chain to China and weak crude oil prices

Indian pharma majors step in to develop, import coronavirus test kits

The rapid test uses a blood sample and gives results based on detecting the presence of certain antibodies that react to the coronavirus protein

Private labs wait for govt go-ahead to launch coronavirus test kits

ICMR on Saturday said all hospitalised patients who have pneumonia or severe acute respiratory illness will be tested for Covid-19.

The post-COVID-19 world

Policymakers and pharma companies will have to work together to speed up trials of new vaccines and legislate to ensure essential drugs and tests are affordable and available

Covid-19 won't impact credit rating of pharma firms for now: Ind-Ra

If the disruption spills beyond the next 9 to 12 months, some of the higher rated corporates could face downward pressure

Over 8,660 pharma firms claimed tax deduction during 2019-20: I-T dept

The matter will come up again in court on Monday

'Sick' pharma PSU offers to step in to reduce China drug dependence

HAL can make up to 50 per cent of bulk drugs if it is provided financial assistance to upgrade its infrastructure, the company said

Pharma companies can draw $30 bn revenue from US market by tapping 10 drugs

Despite having good demand from across the markets, primarily due to lower prices and easy availability, India controls only 2.4 per cent of global pharma exports

Trivitron Healthcare targets over Rs 1,000-crore revenue in FY22

Trivitron Healthcare currently has nine manufacturing facilities across five locations -- Chennai, Mumbai, Pune, Ankara and Helsinki

Pharma chemical from China and Saudi Arabia faces anti-dumping duty

The company has filed an application before the directorate for investigation into the imports from these countries for imposing anti-dumping duty

Aurobindo Pharma recalls Mirtazapine tablets in US over label error

The product is being recalled due to a label error on declared strength

NCLT dissolves Orchid Pharma's promoter firm, says no gain for shareholders

CoC says parent firm has no assets other than holding in Orchid Pharma, which itself is undergoing CIRP; Even if there is a resolution for Orchid Pharma, nothing would be left for investors

Dr Reddy's gives part manufacturing to China partners to tap local market

The products are manufactured either in the plant owned by KRRP in China, or partners in China, or in India by Dr. Reddy's

Exposure to US market causing constant FDA scrutiny for big drug firms

Dr Reddy's was in the news for falling short of expectations during routine audits conducted by the US drug regulator

Regulatory woes resurface for Indian pharma companies as stocks fall

Concerns over US sales are diluting positives of strong domestic growth, and have led to a 10 per cent fall in the Nifty Pharma index in one month